SWA
Sutton Wealth Advisors’s Enanta Pharmaceuticals ENTA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-509
| Closed | -$23.7K | – | 1036 |
|
|
2022
Q4 | $23.7K | Buy |
509
+1
| +0.2% | +$47 | 0.01% | 629 |
|
|
2022
Q3 | $26.4K | Buy |
508
+3
| +0.6% | +$156 | 0.01% | 569 |
|
|
2022
Q2 | $23.9K | Sell |
505
-6
| -1% | -$284 | 0.01% | 611 |
|
|
2022
Q1 | $36.4K | Buy |
511
+1
| +0.2% | +$71 | 0.01% | 507 |
|
|
2021
Q4 | $38.1K | Buy |
510
+5
| +1% | +$374 | 0.01% | 500 |
|
|
2021
Q3 | $28.7K | Buy |
505
+13
| +3% | +$739 | 0.01% | 578 |
|
|
2021
Q2 | $21.7K | Hold |
492
| – | – | 0.01% | 678 |
|
|
2021
Q1 | $24.3K | Hold |
492
| – | – | 0.01% | 615 |
|
|
2020
Q4 | $20.7K | Hold |
492
| – | – | 0.01% | 602 |
|
|
2020
Q3 | $22.5K | Hold |
492
| – | – | 0.01% | 507 |
|
|
2020
Q2 | $24.7K | Hold |
492
| – | – | 0.01% | 474 |
|
|
2020
Q1 | $25.3K | Hold |
492
| – | – | 0.02% | 415 |
|
|
2019
Q4 | $30.4K | Hold |
492
| – | – | 0.02% | 448 |
|
|
2019
Q3 | $29.6K | Hold |
492
| – | – | 0.02% | 455 |
|
|
2019
Q2 | $41.5K | Hold |
492
| – | – | 0.02% | 347 |
|
|
2019
Q1 | $47K | Hold |
492
| – | – | 0.03% | 313 |
|
|
2018
Q4 | $34.8K | Hold |
492
| – | – | 0.02% | 353 |
|
|
2018
Q3 | $42K | Hold |
492
| – | – | 0.03% | 327 |
|
|
2018
Q2 | $57K | Hold |
492
| – | – | 0.04% | 257 |
|
|
2018
Q1 | $39.8K | Hold |
492
| – | – | 0.03% | 334 |
|
|
2017
Q4 | $28.9K | Hold |
492
| – | – | 0.02% | 424 |
|
|
2017
Q3 | $23K | Hold |
492
| – | – | 0.02% | 498 |
|
|
2017
Q2 | $17.7K | Hold |
492
| – | – | 0.01% | 581 |
|
|
2017
Q1 | $15.2K | Hold |
492
| – | – | 0.01% | 600 |
|
|
2016
Q4 | $16.5K | Hold |
492
| – | – | 0.01% | 554 |
|
|
2016
Q3 | $13.1K | Hold |
492
| – | – | 0.01% | 587 |
|
|
2016
Q2 | $10.8K | Buy |
+492
| New | +$10.8K | 0.01% | 610 |
|